Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Solusi Bangun Indonesia Tbk. (SMCB) vs Tempo Scan Pacific Tbk. (TSPC)

Solusi Bangun Indonesia Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Solusi Bangun Indonesia Tbk. dan Tempo Scan Pacific Tbk.: Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.730 (kapitalisasi pasar 12,36 T, volume 24 jam 1,41 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

SMCBTSPC
Kapitalisasi Pasar
6,99 T12,36 T
Volume
1,41 jt
Lot
14,08 rb
Perputaran
3,83 M
Harga Rata-rata
2.722,04
Nilai Transaksi
3,83 M
Harga Ekuilibrium Indikatif
2.730
Volume Ekuilibrium Indikatif
2,51 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

SMCB
Lihat detail
TSPC
Lihat detail

Tentang Solusi Bangun Indonesia Tbk.

PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.

Selengkapnya di halaman SMCB

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC